Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 13 GUTS Fractyl Health reports Q1 results
May 13 GUTS Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13 GUTS Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
May 11 RGNX Analysts Have Lowered Expectations For REGENXBIO Inc. (NASDAQ:RGNX) After Its Latest Results
May 10 ADVM Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
May 10 RGNX Regenxbio Inc (RGNX) Q1 2024 Earnings: Misses Analyst Revenue and EPS Forecasts
May 10 ADVM Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
May 9 ADVM Adverum Biotechnologies GAAP EPS of -$1.50
May 9 ADVM Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
May 9 RGNX REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
May 9 ADVM Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
May 9 CRGX Is There An Opportunity With CARGO Therapeutics, Inc.'s (NASDAQ:CRGX) 21% Undervaluation?
May 9 RGNX Q1 2024 Regenxbio Inc Earnings Call
May 9 QURE uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 9 RGNX Regenxbio Inc (RGNX) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress and Robust ...
May 9 GNPX Genprex co-founder, CEO passes away
May 9 RGNX REGENXBIO Inc. (RGNX) Q1 2024 Earnings Call Transcript
May 8 GNPX Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
May 8 RGNX Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates
May 8 RGNX Regenxbio GAAP EPS of -$1.38 misses by $0.11, revenue of $15.62M misses by $7.9M
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags